News

Today, The World Health Organization organised a special high-level event to discuss key actions needed at a global and country…

The Centre for Operational Research at The Union, working in close collaboration with the National TB Programme and National AIDS…

The first edition of this vital Union technical guide, entitled Basic occupational safety and health for respiratory diseases: a desk…

Earlier this week, Mr. Navid Ahmed Shaikh, Commissioner Karachi Division, directed his seven deputy commissioners to create district…

We have received an overwhelming response with over 1,300 abstract and session submissions for the 52nd Union World Conference. While COVID19 has made some traction in the submissions this year, it is noteworthy to highlight  that submissions on tuberculosis continue to reign supreme with a huge interest in Access to Quality TB Care and Services, TB diagnostics as well as Active Case Finding and Contact Tracing. There has also been a growing interest in Civil Society, Advocacy and Community Engagement. 

We still have some amazing opportunities to engage in the conference:

- TBScience submissions are now open. Submissions will close on 20 July, 2021 (23:59 CEST). 
- Community Connect submissions are now open. Apply to be a Track Lead by 28 June, 2021 (17:00 CEST). Submissions will close on 21 July, 2021 (17:00 CEST).
- Satellite submissions to remain open till June 30, 2021 (23:59 CEST).
- Registration for the Conference will begin in August.

For any further information, please email: conferences@theunion.org

While all six of the World Health Organization’s cost-effective, high-impact MPOWER measures are critical to ending the global tobacco…

The Union expresses its solidarity with the people of India who are suffering immensely during this current wave of the COVID-19…

The Union congratulates the Kathmandu Institute of Child Health (KIOCH) for rejecting a ‘donation’ of US$ 400,000 and declining a…

The Union supports the call to action to tackle antimicrobial resistance (AMR) by the United Nations Group of Friends on AMR.

In its recently released (16 April) “Final Opinion on Electronic Cigarettes,” the European Union’s Scientific Committee on Health,…

On April 28th, Mexico’s Chamber of Deputies voted unanimously to strengthen its tobacco control law; 415 Congressional members supported…

A huge body of research demonstrates that tobacco growing is neither safe—it results in green tobacco sickness—nor lucrative, with the…

With support from The Union, Mexico’s National Institute of Health conducted a systematic literature review of nearly one thousand…

All content in PHA is Open Access and free to read. PHA covers all areas of operational research including: infection control, nutrition…

This Earth Day, we highlight two preprints accepted for the June issue of PHA. The articles by Sinha et al. and Harries and co-authors …

Indonesia is unduly burdened by tobacco: it has a has a 63% male smoking prevalence, and smoking causes approximately 235,000 deaths…

India’s Cigarettes and Other Tobacco Products Act 2003 (COTPA) bars tobacco company corporate social responsibility (CSR) as does…

The authors conducted a retrospective analysis to determine the proportion of asymptomatic COVID-19 in the workplace during lockdown in early 2020. Nearly 45% of cases were asymptomatic, which has implications for interventions, such as enforcing quarantine of all close contacts of COVID-19 cases regardless of symptoms.

The authors conducted a retrospective analysis to determine the proportion of asymptomatic COVID-19 in the workplace during lockdown in early 2020. Nearly 45% of cases were asymptomatic, which has implications for interventions, such as enforcing quarantine of all close contacts of COVID-19 cases regardless of symptoms.

The Union in partnership with TB Alert, WHO Regional Office for Europe and the Stop TB partnership today released a new guide “…

On 8 April, Muhammadiyah, one of Indonesia’s largest, most influential civil society organisations, organised a high-level meeting to…

At a meeting on 31 March, newly appointed Makassar Mayor Mr Ramadhan Pomanto urged the 1.5 million residents of Eastern Indonesia’s…

In this recently accepted article for IJTLD, the authors performed a cohort-comparison study to assess Pretomanid in a regimen to treat drug-resistant TB: patients receiving the BPaL regimen had a significantly better 6-month post-treatment outcome than those on the B–L regimen. The preprint is free to read.

In this recently accepted article for IJTLD, the authors performed a cohort-comparison study to assess Pretomanid in a regimen to treat drug-resistant TB: patients receiving the BPaL regimen had a significantly better 6-month post-treatment outcome than those on the B–L regimen. The preprint is free to read.

In this recently accepted Review for IJTLD, the authors summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts.